CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BGI Genomics Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BGI Genomics Co Ltd
Ole Maaloees Vej 3, Copenhagen N
Phone: +86 75536307065p:+86 75536307065 SHENZHEN, GNG  518083  China Ticker: 300676300676
Business Summary
BGI Genomics Co Ltd is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as drugs basic research and clinical application services. The Company mainly provides services for domestic and overseas academic institutions, research institutes, independent laboratories, pharmaceutical companies, hospitals and medical institutions, among others. The Company mainly operates its businesses in domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
8071 Medical laboratories
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JianWang 70
Vice Chairman of the Board YeYin 45 6/16/2021
Chief Financial Officer YujueWang 46 6/16/2021 6/16/2021
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 3,752 (As of 12/31/2023)
Outstanding Shares: 413,914,325 (As of 12/31/2023)
Shareholders: 69,673
Stock Exchange: SHE
Fax Number: +86 75536307035


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024